Status:
COMPLETED
Hydrodissection in Carpal Tunnel Syndrome
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Carpal Tunnel Syndrome
Median Nerve Entrapment
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The aim of this study was to compare the effectiveness of perineural hydrodissection methods performed with 5 mL D5W solution and three different injection techniques \[ultrasound-guided in-plane, ult...
Detailed Description
Carpal tunnel syndrome (CTS) is a highly prevalent condition in the general population, markedly impairing daily activities and sleep quality. Depending on disease severity and symptom burden, treatme...
Eligibility Criteria
Inclusion
- Patients between the ages of 20-70
- Moderate and mild CTS patients diagnosed with CTS by EMG
- Literate patients who agreed to participate in the study
Exclusion
- Patients with RA, type 1 or type 2 diabetes mellitus
- Patients with chronic renal failure
- Polyneuropathy
- Those with a history of cancer, those receiving chemotherapy
- Those with a history of broken hand wrist fracture in the last 6 months
- Patients with brachial plexopathy or thoracic outlet syndrome (TOS)
- Patients who underwent surgery due to CTS
- Pregnancy
- Hypothyroidism in a mixed edema picture
- Diagnosed with neuromuscular disease
- Patients with bleeding disorders or those currently receiving anticoagulant therapy
- patients with infection at the injection site
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT07207460
Start Date
January 1 2024
End Date
August 1 2025
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)